Personalized Medicine News and Research

RSS

Organoid coculture platforms enhance preclinical prediction of drug efficacy

Three‐dimensional cancer organoids cultured in vitro closely recapitulate the phenotypic and genetic features of parental tumor tissues, making them powerful tools for cancer research, drug screening, and personalized medicine.

5 Nov 2026

New strategy identified for overcoming resistance to KRAS-targeted cancer therapies

Researchers at Roswell Park Comprehensive Cancer Center have identified a promising strategy for overcoming one of the biggest challenges facing KRAS-targeted cancer therapies: treatment resistance.

30 Oct 2026

Mount Sinai ranks third globally among the world's smartest hospitals

The Mount Sinai Hospital has been ranked No. 3 in the world on Newsweek's "World's Best Smart Hospitals" list, rising two places from No. 5 last year and maintaining its No. 1 ranking in New York State for the second consecutive year. Mount Sinai Morningside and Mount Sinai West ranked No. 7 in New York State on the same list.

30 Oct 2026

Physical activity may help lower genetic risk of depression in adults

Adding physical activity to a daily routine may seem like a simple step for better health, but research from Kansas State University suggests it could be especially beneficial for individuals with a genetic predisposition to depression, potentially helping reduce their risk and ease their symptom burden.

26 Oct 2026

Mount Sinai wins NIH grant to test community-based hypertension care model in rural Ghana

Researchers at the Icahn School of Medicine at Mount Sinai have received a $3.3 million, five-year grant from the National Heart, Lung, and Blood Institute, part of the National Institutes of Health, to test an innovative community-based primary care model for high blood pressure in rural Ghana.

15 Oct 2026

Precise brain circuit targeting may improve depression treatment outcomes

Stimulation of specific brain connections was associated with sustained improvement in people receiving deep brain stimulation (DBS) for treatment-resistant depression, Mount Sinai researchers reported.

14 Oct 2026

New model predicts growth hormone therapy response in children with short stature

Idiopathic short stature (ISS) describes children whose height is substantially below the expected range for their age and sex without any identifiable medical cause.

5 Oct 2026

New study investigates PFAS exposure and future inflammatory bowel disease

Exposure to per- and polyfluoroalkyl substances (PFAS), often called "forever chemicals," may play a role in the development of inflammatory bowel disease (IBD) years before symptoms appear, according to a new five-year study supported by a $3.3 million National Institutes of Health (NIH) R01 grant to researchers at the Icahn School of Medicine at Mount Sinai.

5 Oct 2026

Mount Sinai researchers discover how Alzheimer's gene damages blood vessels

Mount Sinai researchers have identified how APOE4, the strongest genetic risk factor for Alzheimer's disease, damages the brain's blood vessels and promotes the buildup of abnormal proteins linked to neurodegenerative disease.

24 Sep 2026

Wildfire smoke poses greater health risks than other pollution

As climate change drives more frequent and intense wildfires, researchers at the Icahn School of Medicine at Mount Sinai have published two large-scale studies showing that wildfire smoke may pose greater health risks than other sources of air pollution, with higher risks of hospitalization for cardiovascular and respiratory disease and poorer survival among patients with lung cancer.

17 Sep 2026

New project aims to diagnose asthma in young children

Although asthma is the most common chronic condition in childhood, current tests can only diagnose it from the age of five.

17 Sep 2026

Neighborhood environments impact long-term health of 9/11 responders

Twenty-five years after the September 11 terrorist attacks, researchers at the Icahn School of Medicine at Mount Sinai have found that environmental conditions where World Trade Center responders live may influence their long-term physical and mental health.

11 Sep 2026

Scientists develop lab-grown heart tissue model for heart failure

Scientists study the underlying causes of a disease or test new potential drugs in animal models or cells obtained from human biopsy specimens before clinical trials.

2 Sep 2026

NIH grant funds research on environmental triggers for sickle cell disease

The Icahn School of Medicine at Mount Sinai has received a $4.1 million grant from the National Heart, Lung, and Blood Institute, part of the National Institutes of Health, to study how everyday exposures affect the health of people with sickle cell disease.

1 Sep 2026